Silihan lan utang jangka dawa perusahaan EDAP TMS S.A. (EDAP)

EDAP TMS S.A. (EDAP) controls the market for robotic ultrasound systems, transforming clinics into high-tech centers for indispensable treatment. The asset's price trajectory is accompanied by the 0.02 indicator. The company possesses exceptional pricing power over its HIFU devices for prostate therapy due to low demand elasticity. Its status as a global leader is cemented by lengthy certification periods and the complexity of physician training, which blocks the entry of new players.

For EDAP TMS S.A., the company's long-term debt reflects the volume of capital obligations directed toward the modernization of high-tech ultrasound equipment production in France and the procurement of precision components. This indicator aggregates all loans and bonds with maturities exceeding one year, allowing investors to assess the sustainability of financial leverage and the debt load risk relative to the business's market value.